Canada Pension Plan Investment Board’s Achillion Pharmaceuticals ACHN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-31,414	Closed	-$93K	–	1624
2019 Q1	$93K	Buy	+31,414	New	+$77.2K	﹤0.01%	1275
2017 Q2	–	Sell	-35,800	Closed	-$151K	–	1190
2017 Q1	$151K	Buy	35,800 +1,600	+5%	+$6.64K	﹤0.01%	1046
2016 Q4	$141K	Sell	34,200 -800	-2%	-$4.25K	﹤0.01%	970
2016 Q3	$284K	Buy	35,000 +7,100	+25%	+$60.4K	﹤0.01%	927
2016 Q2	$218K	Buy	27,900 +10,400	+59%	+$89.2K	﹤0.01%	952
2016 Q1	$135K	Sell	17,500 -2,300	-12%	-$16.8K	﹤0.01%	1032
2015 Q4	$214K	Buy	19,800 +8,100	+69%	+$73.6K	﹤0.01%	1005
2015 Q3	$81K	Buy	11,700 +7,800	+200%	+$63.5K	﹤0.01%	1129
2015 Q2	$35K	Buy	+3,900	New	+$36.9K	﹤0.01%	1208

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Pension Plan Investment Board's ACHN Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Achillion Pharmaceuticals (ACHN) in Q2 2019, closing a stake of 31,414 shares — an estimated $93K sold.

Canada Pension Plan Investment Board first reported a position in ACHN in Q2 2015 and held it in 9 quarters. The position peaked at $284K in Q3 2016. 114 funds tracked by Wall St. Rank hold ACHN as of Q2 2019.

Canada Pension Plan Investment Board reported no remaining Achillion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Canada Pension Plan Investment Board sold 31,414 Achillion Pharmaceuticals shares in Q2 2019, an estimated $93K.
Canada Pension Plan Investment Board first reported a position in Achillion Pharmaceuticals in Q2 2015 and held it in 9 quarters.
Canada Pension Plan Investment Board's Achillion Pharmaceuticals position peaked at $284K in Q3 2016.
114 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.